News Image

NASDAQ:PGNY—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

By Mill Chart

Last update: Dec 13, 2023

In this article we will dive into PROGYNY INC (NASDAQ:PGNY) as a possible candidate for growth investing. Investors should always do their own research, but we noticed PROGYNY INC showing up in our strong growth, ready to breakout screen, which makes it worth to investigate a bit more.

Growth Insights: NASDAQ:PGNY

ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NASDAQ:PGNY scores a 8 out of 10:

  • PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.81%, which is quite impressive.
  • PGNY shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.53%.
  • Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 74.52% on average per year.
  • The Earnings Per Share is expected to grow by 45.53% on average over the next years. This is a very strong growth
  • PGNY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.58% yearly.

What does the Health looks like for NASDAQ:PGNY

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:PGNY has received a 8 out of 10:

  • PGNY has an Altman-Z score of 12.17. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 12.17, PGNY belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
  • There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • PGNY has a Current Ratio of 3.16. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.16, PGNY belongs to the top of the industry, outperforming 87.83% of the companies in the same industry.
  • PGNY has a Quick Ratio of 3.16. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
  • PGNY has a better Quick ratio (3.16) than 87.83% of its industry peers.

Looking at the Profitability

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:PGNY, the assigned 6 is a significant indicator of profitability:

  • PGNY has a Return On Assets of 7.16%. This is amongst the best in the industry. PGNY outperforms 87.83% of its industry peers.
  • PGNY's Return On Equity of 10.09% is fine compared to the rest of the industry. PGNY outperforms 75.65% of its industry peers.
  • PGNY has a Return On Invested Capital of 7.66%. This is in the better half of the industry: PGNY outperforms 79.13% of its industry peers.
  • The last Return On Invested Capital (7.66%) for PGNY is above the 3 year average (6.26%), which is a sign of increasing profitability.
  • Looking at the Profit Margin, with a value of 5.03%, PGNY belongs to the top of the industry, outperforming 83.48% of the companies in the same industry.
  • With a decent Operating Margin value of 5.00%, PGNY is doing good in the industry, outperforming 65.22% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PGNY has grown nicely.

Why is NASDAQ:PGNY a setup?

In addition to the Technical Rating, ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the level of consolidation in the stock based on multiple short-term technical indicators. Currently, NASDAQ:PGNY has a 7 as its setup rating, indicating its current consolidation status.

Although the technical rating is only medium, PGNY does present a nice setup opportunity. Prices have been consolidating lately and the volatility has been reduced. There is a resistance zone just above the current price starting at 36.15. Right above this resistance zone may be a good entry point. Another positive sign is the recent Pocket Pivot signal.

Our Strong Growth screener lists more Strong Growth stocks and is updated daily.

Check the latest full fundamental report of PGNY for a complete fundamental analysis.

Our latest full technical report of PGNY contains the most current technical analsysis.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

PROGYNY INC

NASDAQ:PGNY (4/18/2024, 7:13:59 PM)

Premarket: 31.77 -0.11 (-0.35%)

31.88

-0.87 (-2.66%)

PGNY News

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of...

News Imagea month ago - ProgynyProgyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Imagea month ago - BusinessInsiderThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wagering on mid-cap stocks can potentially unlock investment treasures typicall...

News Imagea month ago - ProgynyProgyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Seeking AlphaProgyny announces $100M share repurchase program (NASDAQ:PGNY)

Progyny (PGNY) approves $100 million share repurchase program funded by available cash balances.

News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program
News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Market News VideoWednesday Sector Laggards: Hospital & Medical Practitioners, Oil & Gas Refining & Marketing Stocks
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint

PGNY Links
Follow us for more